Literature DB >> 1293056

Intracellular bactericidal activity of fosfomycin against staphylococci: a comparison with other antibiotics.

M Trautmann1, C Meincke, K Vogt, M Ruhnke, A M Lajous-Petter.   

Abstract

The intracellular bactericidal activity of fosfomycin was compared to that of other anti-staphylococcal agents. Two staphylococcal strains (one isolate of Staphylococcus aureus and one isolate of Staphylococcus epidermidis) were incubated in vitro with human granulocytes isolated from volunteers. After phagocytosis and removal of residual extracellular bacteria, the cells were resuspended in the presence of clinically relevant concentrations of fosfomycin, teicoplanin, vancomycin and rifampin. The number of bacteria surviving intracellularly was determined by colony counts after osmotic lysis of the granulocytes at different time intervals. Incubation with fosfomycin resulted in a mean reduction of intracellular bacteria by approximately two logs of ten within 18 h for both staphylococcal strains. Although less effective than rifampin, fosfomycin showed a significantly higher intracellular activity than the glycopeptide antibiotics in this model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293056     DOI: 10.1007/bf01710683

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages.

Authors:  N A Carlone; A M Cuffini; M Ferrero; V Tullio; G Avetta
Journal:  J Antimicrob Chemother       Date:  1989-06       Impact factor: 5.790

2.  Activity of intracellular antibiotics.

Authors:  P Van der Auwera; G Prinz; G Petrikkos
Journal:  Infection       Date:  1991       Impact factor: 3.553

3.  Effect of phenylbutazone on phagocytosis and intracellular killing by guinea pig polymorphonuclear leukocytes.

Authors:  R R Strauss; B B Paul; A J Sbarra
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

Review 4.  Recurrent staphylococcal skin infections.

Authors: 
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

5.  Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.

Authors:  T Bergan
Journal:  Chemotherapy       Date:  1990       Impact factor: 2.544

6.  Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

7.  Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.

Authors:  G A Dette; H Knothe; B Schönenbach; G Plage
Journal:  J Antimicrob Chemother       Date:  1983-06       Impact factor: 5.790

8.  [The effect of cefaclor, doxycycline and other oral antibiotics on phagocytosis of polymorphonuclear granulocytes and PHA-induced stimulation of blood lymphocytes in man].

Authors:  H Hahn; D Kuhring; M Trautmann; T Diamantstein
Journal:  Arzneimittelforschung       Date:  1985

9.  Fosfomycin-ampicillin versus gentamicin-ampicillin in the treatment of critically ill patients with pneumonia.

Authors:  L R Nissen; J Jacobsen; T J Ravn; C Wahlgreen; H Auning-Hansen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

10.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

View more
  9 in total

Review 1.  [Antimicrobial prosthesis coatings].

Authors:  S Gravius; D C Wirtz
Journal:  Orthopade       Date:  2015-12       Impact factor: 1.087

Review 2.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 3.  Fracture-related infection.

Authors:  T Fintan Moriarty; Willem-Jan Metsemakers; Mario Morgenstern; Marloes I Hofstee; Alejandro Vallejo Diaz; James E Cassat; Britt Wildemann; Melissa Depypere; Edward M Schwarz; R Geoff Richards
Journal:  Nat Rev Dis Primers       Date:  2022-10-20       Impact factor: 65.038

4.  Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.

Authors:  C O Onyeji; C H Nightingale; M N Marangos
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

Review 5.  Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

Review 6.  Fosfomycin: Uses and potentialities in veterinary medicine.

Authors:  D S Pérez; M O Tapia; A L Soraci
Journal:  Open Vet J       Date:  2014-03-16

Review 7.  Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review.

Authors:  Suzanne Bongers; Pien Hellebrekers; Luke P H Leenen; Leo Koenderman; Falco Hietbrink
Journal:  Antibiotics (Basel)       Date:  2019-05-04

8.  Penetration of fosfomycin into IPEC-J2 cells in the presence or absence of deoxynivalenol.

Authors:  Guadalupe Martínez; Denisa S Pérez; Alejandro L Soraci; María O Tapia
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

Review 9.  Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada.

Authors:  George G Zhanel; Michael A Zhanel; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-06-25       Impact factor: 2.471

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.